IDH1 and central nervous system cancer: Isocitrate dehydrogenase 1 (IDH1) mutations are genetic alterations that are considered driver mutations and occur in 70–90% of lower-grade gliomas (LGG) [1]; however, faithful models that recapitulate this disease are sparse.